Detalhe da pesquisa
1.
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials.
Lancet
; 401(10378): 747-761, 2023 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36746171
2.
Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials.
Br J Dermatol
; 190(6): 836-845, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38470171
3.
Real-world clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study.
J Eur Acad Dermatol Venereol
; 38(2): 340-353, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37669868
4.
The use of ultrasound and magnetic resonance imaging in the management of hidradenitis suppurativa: a narrative review.
Br J Dermatol
; 188(5): 591-600, 2023 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36753411
5.
Bruton's tyrosine kinase inhibition-An emerging therapeutic strategy in immune-mediated dermatological conditions.
Allergy
; 77(8): 2355-2366, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35175630
6.
Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: A post hoc integrated analysis of 3 phase 3 randomized, double-blind, placebo-controlled trials.
J Am Acad Dermatol
; 87(4): 784-791, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35714786
7.
Persistence, effectiveness, and real-world outcomes in psoriasis patients treated with secukinumab in Portugal.
Dermatol Ther
; 35(7): e15510, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35419886
8.
Beyond striae cutis: A case report on how physical skin complaints unveiled end-of-life total experience.
Palliat Support Care
; 19(1): 119-121, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32856581
9.
Dupilumab-associated facial and neck dermatitis successfully treated with baricitinib.
J Dtsch Dermatol Ges
; 22(5): 704-705, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38470157
10.
Secondary Skin Plasmacytomas.
Skinmed
; 15(2): 153-155, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28528616
11.
Secukinumab: A complete approach to psoriatic patients-Real-world evidence study.
Dermatol Ther
; 34(2): e14815, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33497528
12.
Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study.
J Am Acad Dermatol
; 81(1): 273-275, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30790602
13.
From PsO to PsA: the role of TRM and Tregs in psoriatic disease, a systematic review of the literature.
Front Med (Lausanne)
; 11: 1346757, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38405187
14.
Tildrakizumab for the treatment of moderate-to-severe psoriasis: a 52-week, real-world Portuguese multicentric study.
Drugs Context
; 132024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38510314
15.
Lichen planus pemphigoides.
J Dtsch Dermatol Ges
; 16(3): 335-337, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29537153
16.
Lichen planus pemphigoides.
J Dtsch Dermatol Ges
; 16(3): 335-337, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29465781
17.
Epidemiology of Psoriasis in Portugal: A Population-Based Study.
Acta Med Port
; 36(9): 541-549, 2023 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36608696
18.
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials.
JAMA Dermatol
; 159(5): 526-535, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37043227
19.
Dermoscopic and reflectance confocal microscopic presentation of relapsing eccrine porocarcinoma.
J Am Acad Dermatol
; 76(2S1): S73-S75, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28087039
20.
Multiple annular plaques on a 9-year-old boy.
Pediatr Dermatol
; 34(6): 713-714, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29144040